Insights
What we are working through.
On agentic AI in commercial pharma, NHS market access, and the analytics practice behind both. We write when we have learned something, not on a content calendar.
Next Best Action in Commercial Pharma
In the past, pharmaceutical companies have invested heavily in Next Best Action (NBA) initiatives—rule engines, propensity models, dashboards, and AI-driven recommendations to improve field force effectiveness. Yet the gap persists. Field teams still struggle with...
Targeting and Segmentation as a service
Why Targeting and Segmentation as a service Bringing a drug to market is never simple—especially...
SFE Analytics Without the Overhead – Solution for agile Pharma & Biotech
Commercialising a drug is never easy—especially for small to medium-sized pharmaceutical and...
Blog Writer Genie: Transforming Technical Content Creation with SnapLogic’s GenAI Platform
Introduction Generative AI (GenAI) is no longer just a tech trend—it’s become a powerful tool...
Navigating the drug’s launch in NHS
The NHS drugs bill is estimated to be £20 billion in 2020/21. This is a massive market for any...
Guidance anomalies-analytic tools to alert priorities.
How does Commercial Pharma align to NHS guidance opportunities? Formulary Analytics enables...
Work with us
With a personal point of contact and a bespoke approach, we help you gain the actionable insight that moves your business forward.